Xigris

An Investment Company Strategy:   The core of the Company's strategy will be to make direct and indirect investments in natural resources companies and projects, both listed and unlisted, that the directors of the Company (the "Directors") consider to be undervalued or have strong fundamentals and attractive growth prospects. Natural resources companies or projects, for the purposes of the investing policy, are those involved in the…

Hi Paul and Cisk, Deltex may well succeed as a company, I wish it and all its investors well.   The following is a simplification and is intended to provide some background information only. Haemodynamic monitoring The issue of advanced haemodynamic monitoring is not straight forward. The 'Gold' Standard product used to be the Pulmonary Artery Flotation catheter. Studies like PAC-man did not show a survival…

This is my specialist area of medical practice.Just a note of caution about Deltex Medical (LON:DEMG). They have direct competitors:Lidco (LON:LID) http://www.lidco.comPulsion http://www.pulsion.com/?id=35Edwards Lifesciences http://www.edwards.com/products/mininvasive/Pages/MinInvasiveHome.aspxAll 4 companies have been pushing their products for years, and the evidence is not as certain as they would have you believe. Each of these companies may be hugely successful, but it is not a done deal. There are a…

I don't post very often because of my day job and I don't usually have anything worth saying. However, for the first time ever, I thought I'd email SOCO International (LON:SIA) to see if they were in a position to comment on whether there is an independent review of reserves and its timing. This is their reply: Thank you for your enquiry through our website. …

Thanks for bringing this up again Mark. I'm sorry that my day job and other commitments prevent me from posting here as often as I'd like. I've edited down the header. I don't want to mislead anyone with out of date info. All the best, Chris Long POL, AEX

Interesting take from Lexhttp://www.ft.com/cms/s/3/b81c6984-cd92-11e0-b267-00144feabdc0.html#axzz1VhPmy9ySInvestors who do not match the buy-back with a proportionate sale are in effect buying more shares. That hurts whenever companies buy back at the wrong time.Xig